Total submissions: 17
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000679670 | SCV000261717 | benign | not provided | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000679670 | SCV000520975 | likely benign | not provided | 2020-07-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000565304 | SCV000671241 | likely benign | Hereditary cancer-predisposing syndrome | 2015-06-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV000679670 | SCV000806847 | likely benign | not provided | 2017-05-09 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000425210 | SCV000888570 | benign | not specified | 2017-06-09 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000679670 | SCV001148866 | likely benign | not provided | 2025-02-01 | criteria provided, single submitter | clinical testing | POLE: BP4, BP7 |
Genetic Services Laboratory, |
RCV000425210 | SCV002066433 | likely benign | not specified | 2021-11-22 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000565304 | SCV002536925 | benign | Hereditary cancer-predisposing syndrome | 2020-09-16 | criteria provided, single submitter | curation | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000425210 | SCV002548401 | benign | not specified | 2022-05-05 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000425210 | SCV002550018 | likely benign | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV001080214 | SCV004016720 | benign | Colorectal cancer, susceptibility to, 12 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000679670 | SCV004562288 | likely benign | not provided | 2023-03-24 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000679670 | SCV005217301 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV000679670 | SCV001809631 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000425210 | SCV001926063 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000679670 | SCV001959861 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000679670 | SCV001973086 | likely benign | not provided | no assertion criteria provided | clinical testing |